Seelos Therapeutics, Inc. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/81e88243-e354-4c30-b7c5-de393c63d270/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $2.2M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000140 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001136261-21-000034 |
| FY 2019 | $375.0k | 2019-01-01 – 2019-12-31 | evidence 0001136261-20-000092 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001136261-20-000092 |
| FY 2017 | $511.0k | 2017-01-01 – 2017-12-31 | evidence 0001136261-19-000121 |
| FY 2016 | $5.8M | 2016-01-01 – 2016-12-31 | evidence 0001017491-17-000030 |
| FY 2015 | $4.8M | 2015-01-01 – 2015-12-31 | evidence 0001017491-16-000112 |
| FY 2014 | $9.3M | 2014-01-01 – 2014-12-31 | evidence 0001017491-15-000032 |
| FY 2013 | $2.5M | 2013-01-01 – 2013-12-31 | evidence 0001017491-14-000052 |
| FY 2012 | $7.9M | 2012-01-01 – 2012-12-31 | evidence 0001017491-14-000052 |
| FY 2011 | $3.6M | 2011-01-01 – 2011-12-31 | evidence 0001017491-14-000052 |
| FY 2010 | $5.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-13-111046 |
| FY 2009 | $3.0M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-014548 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Seelos Therapeutics, Inc. — all facts · Net Income · Operating Income